sthma patients still often end up in the emergency room with respiratory problems. Possibly would not work a astmapuffer of the Sandoz brand. The association of pulmonologists want this inhaler is not provided anymore.
The adverse reaction Lareb institute now has 63 reports received within the inhaler with the drug salbutamol. Half of these are children under 12 years. 22 of the patients with asthma who made a notification, were admitted to the hospital. "There are even pediatricians who say we see every week somebody coming," said Agnes Kant, director of Lareb.
reduced effect
The agent has long been on the market, but the producer has changed its composition in 2014. "Since then we get complaints that the agent would have a diminished effect," says Kant.
Salbutamol is used in acute cases of distress. In that the means in some patients no lighting seems to offer more, which end up with respiratory problems in the hospital. Then doctors should prescribe the violent means prednisone to get the problem under control.
indistinctness
"It's still not clear what is going on, but we have determined that something is going on," says Kant. Yet the college that drugs being judges decided to take the plea of the market.The association of pulmonologists now calls nevertheless on the way not to spend more, until there is more clarity.
A spokesman for manufacturer Sandoz has announced to take the complaints seriously.
"The product has been studied to date twice and when no product failures were observed. In eighteen countries, we offer the product and just in the Netherlands we have received so far complaints. Globally, we have sold millions of puffers. The number of reports is free small. the conclusion that the drug would not work, is premature. "
By Editorial RTL News: Photo: Getty
Reactie plaatsen
Reacties